Holen Sie sich die Stockscreener-App
9.93
0.90%
-0.09
Handel nachbörslich:
9.93
Schlusskurs vom Vortag:
$10.02
Offen:
$9.99
24-Stunden-Volumen:
1.61M
Relative Volume:
0.32
Marktkapitalisierung:
$3.06B
Einnahmen:
$571.16M
Nettoeinkommen (Verlust:
$-38.10M
KGV:
-81.06
EPS:
-0.1225
Netto-Cashflow:
$-48.91M
1W Leistung:
+3.87%
1M Leistung:
+12.08%
6M Leistung:
+62.79%
1J Leistung:
-0.30%
1-Tages-Spanne:
$9.88
$10.04
1-Wochen-Bereich:
$9.52
$10.57
52-Wochen-Spanne:
$5.51
$10.57
Amicus Therapeutics Inc Stock (FOLD) Company Profile
Firmenname
Amicus Therapeutics Inc
Sektor
Branche
Telefon
(609) 662-2000
Adresse
47 HULFISH STREET, PRINCETON, NJ
Vergleichen Sie FOLD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FOLD
Amicus Therapeutics Inc
|
9.93 | 3.09B | 571.16M | -38.10M | -48.91M | -0.1225 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.61 | 109.65B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
780.19 | 82.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.23 | 58.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
911.98 | 56.50B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
207.77 | 43.62B | 447.02M | -1.18B | -906.14M | -6.1812 |
Amicus Therapeutics Inc Stock (FOLD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-18 | Hochstufung | Needham | Hold → Buy |
| 2025-07-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-13 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-09-06 | Eingeleitet | Jefferies | Buy |
| 2024-05-30 | Eingeleitet | Wells Fargo | Overweight |
| 2024-05-14 | Hochstufung | Guggenheim | Neutral → Buy |
| 2023-12-19 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-09-09 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-04-13 | Fortgesetzt | Goldman | Neutral |
| 2022-01-14 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2021-11-15 | Hochstufung | Stifel | Hold → Buy |
| 2021-09-30 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-07-19 | Fortgesetzt | BTIG Research | Buy |
| 2021-05-27 | Eingeleitet | Needham | Hold |
| 2021-05-21 | Eingeleitet | UBS | Buy |
| 2021-04-14 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2021-03-02 | Eingeleitet | Stifel | Hold |
| 2021-02-12 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-02-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-12-28 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-12-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-11-11 | Eingeleitet | Berenberg | Hold |
| 2020-06-17 | Eingeleitet | BTIG Research | Buy |
| 2020-02-04 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2019-11-12 | Bestätigt | H.C. Wainwright | Buy |
| 2019-06-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-06-05 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2019-04-05 | Eingeleitet | Janney | Buy |
| 2019-01-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-10-29 | Eingeleitet | Citigroup | Neutral |
| 2018-08-17 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2017-10-06 | Fortgesetzt | Goldman | Neutral |
| 2017-09-13 | Bestätigt | Chardan Capital Markets | Buy |
| 2017-08-10 | Bestätigt | Chardan Capital Markets | Buy |
| 2017-01-24 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2016-05-18 | Eingeleitet | BofA/Merrill | Buy |
| 2016-04-14 | Eingeleitet | Robert W. Baird | Neutral |
| 2016-04-12 | Bestätigt | Chardan Capital Markets | Buy |
| 2015-09-16 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2015-06-16 | Bestätigt | Chardan Capital Markets | Buy |
Alle ansehen
Amicus Therapeutics Inc Aktie (FOLD) Neueste Nachrichten
Assessing Amicus Therapeutics (FOLD) Valuation as Shares Gain 11% Over Past Month - Yahoo Finance UK
How Strong Galafold and Pombiliti Sales Helped Amicus Therapeutics (FOLD) Surpass Expectations and Shift Its Outlook - Yahoo Finance UK
Intech Investment Management LLC Sells 47,907 Shares of Amicus Therapeutics, Inc. $FOLD - MarketBeat
Amicus Therapeutics, Inc. $FOLD Stock Holdings Increased by Jefferies Financial Group Inc. - MarketBeat
Envestnet Asset Management Inc. Has $368,000 Stock Holdings in Amicus Therapeutics, Inc. $FOLD - MarketBeat
David Michael Clark Sells 25,643 Shares of Amicus Therapeutics (NASDAQ:FOLD) Stock - MarketBeat
Amicus Therapeutics (NASDAQ:FOLD) Insider Ellen Rosenberg Sells 23,621 Shares - MarketBeat
Universal Beteiligungs und Servicegesellschaft mbH Acquires 95,565 Shares of Amicus Therapeutics, Inc. $FOLD - MarketBeat
Insider Sell Alert: David Clark Sells 25,643 Shares of Amicus Th - GuruFocus
Wall Street Analysts Think Amicus Therapeutics (FOLD) Could Surge 58.46%: Read This Before Placing a Bet - Finviz
Amicus Therapeutics chief legal officer sells $958k in stock By Investing.com - Investing.com UK
Amicus Therapeutics (NASDAQ:FOLD) Sets New 12-Month HighWhat's Next? - MarketBeat
AXQ Capital LP Makes New $290,000 Investment in Amicus Therapeutics, Inc. $FOLD - MarketBeat
Amicus Therapeutics stock hits 52-week high at $10.36 By Investing.com - Investing.com Nigeria
Amicus Therapeutics stock hits 52-week high at $10.36 - Investing.com
Amicus Therapeutics Inc AM6 Stock Analysis and ForecastIndustrial Stocks Review & Rapid Profit Growth - earlytimes.in
What analysts say about Amicus Therapeutics Inc stockDividend Yield Trends & These Stocks Are Just Getting Started - earlytimes.in
Primecap Management Co. CA Sells 123,400 Shares of Amicus Therapeutics, Inc. $FOLD - MarketBeat
First Week of July 2026 Options Trading For Amicus Therapeutics (FOLD) - Nasdaq
Is Amicus Therapeutics Inc. stock supported by strong fundamentalsAnalyst Upgrade & Daily Stock Trend Reports - newser.com
Vise Technologies Inc. Takes Position in Amicus Therapeutics, Inc. $FOLD - MarketBeat
Is Amicus Therapeutics Inc. stock attractive for growth ETFs2025 Price Momentum & Fast Momentum Entry Tips - newser.com
What insider trading reveals about Amicus Therapeutics Inc. stockTrade Entry Summary & Weekly High Momentum Picks - newser.com
Is Amicus Therapeutics Inc. stock attractive for ETFsInflation Watch & AI Forecasted Stock Moves - newser.com
Published on: 2025-11-20 05:57:54 - newser.com
What RSI levels show for Amicus Therapeutics Inc. (AM6) stockQuarterly Investment Review & Free Expert Approved Momentum Trade Ideas - newser.com
Is Amicus Therapeutics Inc. (AM6) stock vulnerable to rate hikesJuly 2025 Price Swings & Accurate Buy Signal Alerts - newser.com
Institutional scanner results for Amicus Therapeutics Inc.2025 Key Lessons & Weekly Breakout Stock Alerts - newser.com
Is Amicus Therapeutics Inc. trending in predictive chart modelsMarket Activity Recap & Free Fast Gain Swing Trade Alerts - newser.com
Is Amicus Therapeutics Inc. stock in correction or buying zone - newser.com
Why Amicus Therapeutics Inc. stock is a must watch in 20252025 Biggest Moves & Free Safe Capital Growth Stock Tips - newser.com
Is Amicus Therapeutics Inc. meeting your algorithmic filter criteria2025 Technical Patterns & Long-Term Safe Investment Plans - newser.com
Can Amicus Therapeutics Inc. stock maintain growth trajectoryMarket Performance Summary & Growth Focused Entry Reports - newser.com
Does Amicus Therapeutics Inc. stock trade at a discount to peers - newser.com
How forex fluctuations impact Amicus Therapeutics Inc. (AM6) stock2025 Breakouts & Breakdowns & Technical Pattern Recognition Alerts - newser.com
Is Amicus Therapeutics Inc. (AM6) stock good for long term investingShare Buyback & AI Enhanced Market Trend Forecasts - newser.com
Understanding Amicus Therapeutics Inc.’s price movement - newser.com
Is Amicus Therapeutics Inc. (AM6) stock nearing a technical breakoutJuly 2025 Retail & Free High Return Stock Watch Alerts - newser.com
Why Amicus Therapeutics Inc. (AM6) stock is trending on social media2025 Bull vs Bear & Growth-Oriented Investment Plans - newser.com
Published on: 2025-11-18 18:34:31 - newser.com
Finanzdaten der Amicus Therapeutics Inc-Aktie (FOLD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
1.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):